Eledon Pharmaceuticals Inc (ELDN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.42
• Market Cap: $196.69M
• EPS: $-1.30
• 52-Week High: $4.60
• 52-Week Low: $1.35

Market Sentiment

Eledon Pharmaceuticals Inc currently has a Neutral sentiment score of 0.09.

About Eledon Pharmaceuticals Inc

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to innovating therapies for patients with autoimmune diseases and amyotrophic lateral sclerosis (ALS), particularly those in need of organ or cell transplantation. Based in Irvine, California, Eledon is advancing its proprietary drug candidates through clinical trials, aiming to address significant unmet medical needs in these patient populations. With a robust pipeline and a strategic focus on enhancing tran...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Eledon Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ELDN pay dividends?

Eledon Pharmaceuticals Inc (ELDN) does not currently pay a regular dividend.

What is ELDN's market cap?

Eledon Pharmaceuticals Inc (ELDN) has a market capitalization of $196.69M with a current stock price of $2.42.